SCHEMBL8059705

SCHEMBL8059705

COC(=O)c1cc(C(F)(F)F)c(-c2ccccc2)cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 4/20 0.53
S1PR1 P21453 2/20 0.46
LDHA P00338 1/20 0.45
GABRA1 P14867 1/20 0.45
GABRG2 P18507 1/20 0.45
GABRB3 P28472 1/20 0.45
GABRA3 P34903 1/20 0.45
EGFR P00533 1/20 0.45
SLC6A3 Q01959 3/20 0.44
SLC6A4 P31645 2/20 0.44
NOTUM Q6P988 1/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 2/20 0.43
HTT P42858 1/20 0.43
PLK1 P53350 1/20 0.42
HPGD P15428 2/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636502 0.89 CFTR (0.47) CFTRS1PR1LDHAGABRA1GABRG2
SCHEMBL8070699 0.85 TAS2R14 (0.47) S1PR1LDHANOTUMPLK1NTRK1
SCHEMBL3903631 0.80 EGFR (0.57) CFTRS1PR1LDHAEGFRNOTUM
SCHEMBL8068448 0.80 GABRA1 (0.49) GABRA1GABRG2GABRB3GABRA3EGFR
SCHEMBL27661998 0.79 CFTR (0.51) CFTRS1PR1LDHAGABRA1GABRG2
SCHEMBL8071055 0.78 ALDH1A1 (0.51) CFTRGABRA1GABRG2GABRB3GABRA3
SCHEMBL6639916 0.77 CFTR (0.45) CFTRS1PR1LDHAGABRA1GABRG2
SCHEMBL1763845 0.77 CFTR (0.49) CFTRNOTUMHPGDGAA
SCHEMBL8070346 0.77 PDGFRB (0.55) GABRA1GABRG2GABRB3GABRA3EGFR
SCHEMBL6682318 0.77 TAS2R14 (0.50) S1PR1LDHANOTUMPLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057322-A USEFUL IN TREATMENT OF CARDIOVASCULAR DISEASES HOECHST AKTIENGESELLSCHAFT (DE) 2000-05-02 US disclosed